Clinical Trial Update: Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14) [Phase 2]

View source ↗

Summary

Phase 2 trial of venetoclax plus dexamethasone for newly diagnosed light-chain (AL) amyloidosis with t(11;14) translocation; currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Venclexta (venetoclax)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Light Chain (AL) Amyloidosis, CCND1 Translocation | Phase 2 | Status: ACTIVE_NOT_RECRUITING